Veyond Metaverse, the most advanced extended reality (XR) technology platform, is pleased to announce the addition of three new members to its Advisory Board. The new members are Dr. James Snider, John Erickson, and Jim McMenamy. James Snider, a current CEO at Critical Diagnostics, brings unparalleled experience and clinical expertise in the cardiovascular business career spanning three decades. James is a great complement to Veyond Metaverse and adds a unique perspective, given his accomplished cardiovascular IVD and business career.
John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-ups including Johnson & Johnson, Abbott, Bio-Rad, Nexus Dx, and as a consultant to diabetes, clinical diagnostic, and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies, and building high-performance teams. Additionally, John has been responsible for developing, launching, and managing over three dozen scientific products with cumulative revenues in excess of $4 billion and has raised more than $50 million in investment capital. John's experiential portfolio and business acumen also include strategy development and execution, capital funding, organizational design, and cultural change management, numerous global new product launches, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, Digital Health, and Point of Care (POC), and emerging market development expertise. John's experience will be a critical value for Veyond Metaverse.
Jim McMenamy has spent the last 30+ years focusing primarily on the development and worldwide launch of numerous Human and Veterinary Clinical Diagnostic Test Systems with a specific focus on the Point of Care Marketplace. He has launched dozens of new products in Infectious Diseases, Cancer Markers, Fertility Tests, Drugs of Abuse, etc., both Instrumented and non-Instrumented. He has held leadership positions in Marketing, Sales, Business Development, Corporate Development, and General Management with companies such as Samsung (NexusDx), Becton Dickinson, Quidel, ACON Labs, Alere/Inverness Medical, scil/Henry Schein Animal Health, and diatron/Stratec Corp.
"We are very excited to have James, John, and Jim join our Advisory Board here at Veyond Metaverse! The new advisory board is a great complement to our experienced executive team and adds a unique perspective, given their long and successful business career. All three advisors are a well-known leader in the key areas where Veyond Metaverse is focused, making their appointment a strategic and integral part of our company growth."
— Adam Choe, Co-founder, and CEO, Veyond Metaverse About Veyond MetaverseVeyond Metaverse offers a new and disruptive XR technology to medical education, surgical planning, and training, augmented assisted surgical operations, pharmaceutical, oncology treatment, and diagnosis. Our proprietary communication platform enables global engagement and collaboration seamlessly, creating a more accessible, user-friendly ecosystem by leveraging the most advanced communication capabilities. We seek to improve medical education, surgical training, save patients' lives by enhancing surgery, diagnosis, and expand worldwide access through the proprietary cloud platform. Veyond Metaverse is based in Silicon Valley, CA.